Chewy (NYSE:CHWY) reported quarterly sales of $2.43 billion which missed the analyst consensus estimate of $2.48 billion by 2.02 percent. This is a 12.76 percent increase over sales of $2.15 billion the same period last year.
HC Wainwright & Co. Reiterates Buy on ADMA Biologics, Maintains $4.5 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates ADMA Biologics (NASDAQ:ADMA) with a Buy and maintains $4.5 price target.
